Evidence map›Paper›PMID 41689843›Full record

ArticleSubstance use & addiction journal2026

Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use.

Sarah E Leyde, Joseph O Merrill, Anna J Treadway, Kenneth C Pike, Cynthia J Price

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance use & addiction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah E LeydeDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0002-7708-0972
Joseph O MerrillDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.ORCID 0000-0002-5585-9694
Anna J TreadwayDepartment of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, WA, USA.
Kenneth C PikeDepartment of Child, Family and Population Health Nursing, University of Washington, Seattle, WA, USA.
Cynthia J PriceDepartment of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, WA, USA.

Funding

Mindful Body Awareness Training as an Adjunct to Medication Assisted Treatment for Opioid Use Disorder: An ancillary studyR01AT010742 · NCCIH · UNIVERSITY OF WASHINGTON · PI MERRILL, JOSEPH O, PRICE, CYNTHIA J · 2019 to 2022
$2.4M
Mindful Body Awareness Training as an Adjunct to Medication Assisted Treatment for Opioid Use DisorderR33AT009932 · NCCIH · UNIVERSITY OF WASHINGTON · PI PRICE, CYNTHIA J · 2019 to 2021
$2.1M
NCCIH NIH HHS R01 AT010742NCCIH NIH HHS R33 AT009932
6 · The paper itself

Abstract

backgroundCannabis use is prevalent among patients receiving medication for opioid use disorder (MOUD). However, little is known about factors associated with frequent cannabis use.

objectiveTo describe correlates, patterns, and motivations for cannabis use among individuals treated with MOUD.

methodsParticipants from a randomized trial (n = 303) investigating a mind-body intervention adjunct to MOUD were compared based on frequent cannabis use (≥3 days/week) versus less frequent or no use, assessing demographic and clinical characteristics. Individuals with frequent cannabis use were invited to participate in a telephone survey exploring reasons for cannabis use, cannabis usage in treating symptoms/conditions, route, tetrahydrocannabinol/cannabidiol content, and cannabis use disorder screening.

results47.5% of participants (n = 144) endorsed cannabis use, and 27% used cannabis frequently (≥3 days/week). Frequent cannabis use was associated with anxiety (

conclusionsFrequent cannabis use among individuals on MOUD was associated with anxiety, nausea, and lower employment, with no significant differences in key MOUD outcomes including substance use and retention. Individuals with frequent cannabis use reported treating stress, pain, and mental health conditions with cannabis. More attention to screening and treatment of these conditions is warranted.

Indexed as

Marijuana AbuseMarijuana UseMotivationOpiate Substitution TreatmentOpioid-Related DisordersAdultAnxietyEmploymentFemaleHumansMaleMiddle AgedNauseaRandomized Controlled Trials as TopicVomitingbuprenorphinecannabismethadoneopioid use disorder

Identifiers

PMID41689843
PMCPMC13215560

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.